TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/23/2022
Back to search
Official data from USPTO
YUNGSHIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
12/23/2022
Trademark type
Combined
Nice classes
5
Filing date
02/13/2008
Registration date
02/01/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/30/2021
Last transaction
01/30/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2010-01-00
First use in commerce
2010-09-00
Drawing code
3
Owner type
03
Owner location
TACHIA TAICHUNG, TW
Examiner
HAN, DAWN
Law office
L70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
YUNG SHIN PHARM. IND. CO., LTD.
Representatives
Joe McKinney Muncy MUNCY, GEISSLER, OLDS & LOWE, PC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Gastro-intestinal treatment preparations; cough drops; calcium supplement; analgesic preparations; oral analgesics; anti-inflammatories; anesthetics for surgical and non-surgical uses; sedatives; respiratory stimulants; pharmaceutical preparations to enhance digestion; antacids; nausea treatment preparation; diarrhea medications; laxatives; diuretic preparations; antibiotics; hemostatics; appetite suppressants for medical use; diet pills; medicated hair restoration lotions; hair growth stimulants; medicated scalp treatment cream; smoking cessation preparations; eczema treatment preparations; hemorrhoid treatment preparations; psoriasis treatment preparations; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of arthritis; cough treatment preparations; highly caffeinated energy pills; breath-freshening chewing gum for medicinal purposes; blood plasma; antianginal preparation; acne treatment preparations; antipyretic analgesic; muscle relaxants; pharmaceutical anti-allergic preparations and substances; antidepressants; pharmaceutical preparations for the treatment of epilepsypharmaceutical preparations for the treatment of stomach ulcerspharmaceutical preparations for the treatment of tuberculosispharmaceutical preparations for the treatment of Parkinson's diseasepharmaceutical preparations for the treatment of rheumatismpharmaceutical preparations for the treatment of thrombosispharmaceutical preparations for the treatment of enuresispharmaceutical preparations for the treatment of hypertensionpharmaceutical preparations for the treatment of dermatosis; steroid ointments; human hormone for human use; pharmaceutical preparations for the prevention and treatment of disorders of the immune system; antihistamines; bronchodilators; pharmaceutical preparations for skin care; syringes sold filled with hyaluronic acid for use in arthroscopic surgeries; pharmaceutical preparations for the treatment of eye diseases and conditions; anti-cancer preparations; pharmaceutical preparations for treating diabetes; cholesterol reducers; hypnotics; preparations for treating colds; antiarrhythmics; oxytocics; expectorants; uterine contraction pharmaceutical preparations; contraceptives; athletes foot preparations; patches containing mosquito-repellent incenses for human use; vitamins; Chinese medicinesherb teas for medicinal purposespharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceuticalsinducers of erections; hepatotonic agents for hepatological diseases; pharmaceutical preparations for the treatment of liver diseases; vaccines for human purposes; antivirals; ointments for pharmaceutical purposesnon-steroid anti-inflammatory ointments; ocular pharmaceuticalseye-wash; patches containing anti-inflammatories; pharmaceutical preparations for hemopoiesis; vitamin supplement in tablet form for use in making an effervescent beverage when added to water; pharmaceutical preparations for burn treatment; gelatin capsules sold empty for pharmaceuticals; suppositories; insect-repellents; pregnancy test kits for home use; diagnostic test kits consisting of diagnostic preparations for medical purposes; diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; ovulation test kits; mineral nutritional supplements; dietary supplements in capsules containing garlic extract; medicinal ganoderma lucidum extracts for medical purposes; food supplementsanti-oxidants; dietary supplements containing shark cartilage; vitamin and mineral supplements; dietary supplements in capsule forms containing shark liver oils; dietary supplements in capsule forms containing chitin extract; bread that is gluten-free to accommodate special medical and health conditions; dietary and nutritionally fortified food products adapted for medical use; dietary fiber powder as an additive for food products for restricted diet; dandruff shampoo
Publications
History of USPTO decisions and trademark events.
48 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/23/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/23/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/23/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/30/2021
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/30/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/30/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/30/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
11/06/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/01/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/06/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/06/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/06/2016
E815
TEAS SECTION 8 & 15 RECEIVED
09/26/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
02/01/2011
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/28/2010
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
12/27/2010
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/21/2010
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/13/2010
IUAF
USE AMENDMENT FILED
12/10/2010
EISU
TEAS STATEMENT OF USE RECEIVED
12/10/2010
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/13/2010
EX2G
SOU EXTENSION 2 GRANTED
07/12/2010
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/12/2010
EXT2
SOU EXTENSION 2 FILED
06/14/2010
EEXT
SOU TEAS EXTENSION RECEIVED
06/14/2010
EX1G
SOU EXTENSION 1 GRANTED
12/07/2009
EXT1
SOU EXTENSION 1 FILED
12/07/2009
EEXT
SOU TEAS EXTENSION RECEIVED
12/07/2009
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
06/16/2009
PUBO
PUBLISHED FOR OPPOSITION
03/24/2009
NPUB
NOTICE OF PUBLICATION
03/04/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/14/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/14/2009
XAEC
EXAMINER'S AMENDMENT ENTERED
01/02/2009
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/02/2009
GNEA
EXAMINERS AMENDMENT E-MAILED
01/02/2009
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/02/2009
ACEC
AMENDMENT FROM APPLICANT ENTERED
12/12/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/12/2008
ALIE
ASSIGNED TO LIE
12/12/2008
PAPER RECEIVED
12/01/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/30/2008
GNRT
NON-FINAL ACTION E-MAILED
05/30/2008
CNRT
NON-FINAL ACTION WRITTEN
05/30/2008
DOCK
ASSIGNED TO EXAMINER
05/27/2008
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
02/20/2008
NWAP
NEW APPLICATION ENTERED
02/19/2008
Continuous trademark protection
Get notified about every new filing that threatens YUNGSHIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.